James D. Cherry

3.9k total citations · 1 hit paper
47 papers, 2.7k citations indexed

About

James D. Cherry is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, James D. Cherry has authored 47 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 37 papers in Microbiology and 9 papers in Infectious Diseases. Recurrent topics in James D. Cherry's work include Bacterial Infections and Vaccines (37 papers), Pneumonia and Respiratory Infections (31 papers) and Vaccine Coverage and Hesitancy (9 papers). James D. Cherry is often cited by papers focused on Bacterial Infections and Vaccines (37 papers), Pneumonia and Respiratory Infections (31 papers) and Vaccine Coverage and Hesitancy (9 papers). James D. Cherry collaborates with scholars based in United States, Germany and Switzerland. James D. Cherry's co-authors include Ulrich Heininger, K Stehr, Jeffrey Gornbein, Kathleen Harriman, Philip A. Brunell, Gerald S. Golden, David T. Karzon, Kathleen Winter, Wendy A. Keitel and Robert Edelman and has published in prestigious journals such as New England Journal of Medicine, JAMA and PEDIATRICS.

In The Last Decade

James D. Cherry

47 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemic Pertussis in 2012 — The Resurgence of a Vaccine-Preventable Disease

2012 370 citations James D. Cherry New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James D. Cherry United States	26	2.2k	2.2k	606	493	260	47	2.7k
Jann Storsæter Sweden	26	2.0k 0.9×	2.0k 0.9×	595 1.0×	225 0.5×	335 1.3×	50	2.7k
Nancy E. Messonnier United States	28	2.4k 1.1×	2.4k 1.1×	526 0.9×	417 0.8×	110 0.4×	46	3.3k
Kathryn M. Edwards United States	16	2.5k 1.1×	1.6k 0.8×	288 0.5×	145 0.3×	103 0.4×	22	2.8k
Steven G. F. Wassilak United States	28	1.2k 0.5×	793 0.4×	1.2k 2.0×	398 0.8×	128 0.5×	50	2.5k
Nicole Boulianne Canada	32	2.3k 1.0×	759 0.4×	740 1.2×	979 2.0×	74 0.3×	104	2.8k
Adamadia Deforest United States	18	967 0.4×	775 0.4×	363 0.6×	194 0.4×	157 0.6×	42	1.4k
J. Gaudelus France	19	968 0.4×	545 0.3×	395 0.7×	375 0.8×	54 0.2×	146	1.6k
Isabelle Parent du Châtelet France	25	1.4k 0.6×	967 0.4×	452 0.7×	284 0.6×	35 0.1×	66	1.8k
Penina Haber United States	27	1.7k 0.8×	271 0.1×	1.3k 2.2×	906 1.8×	496 1.9×	54	3.4k
Matthew D. Snape United Kingdom	33	2.7k 1.3×	2.0k 0.9×	539 0.9×	286 0.6×	23 0.1×	128	3.7k

Countries citing papers authored by James D. Cherry

Since Specialization

Citations

This map shows the geographic impact of James D. Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Cherry more than expected).

Fields of papers citing papers by James D. Cherry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Cherry. The network helps show where James D. Cherry may publish in the future.

Co-authorship network of co-authors of James D. Cherry

This figure shows the co-authorship network connecting the top 25 collaborators of James D. Cherry. A scholar is included among the top collaborators of James D. Cherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Cherry. James D. Cherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ávila-Agüero, María L., et al.. (2021). Epidemiology of pertussis in Costa Rica and the impact of vaccination: A 58-year experience (1961–2018). Vaccine. 40(2). 223–228. 13 indexed citations

Hoff, Nicole A., Reena H. Doshi, Vivian H. Alfonso, et al.. (2017). Predictors of measles vaccination coverage among children 6–59 months of age in the Democratic Republic of the Congo. Vaccine. 36(4). 587–593. 24 indexed citations

Winter, Kathleen, James D. Cherry, & Kathleen Harriman. (2016). Effectiveness of Prenatal Tetanus, Diphtheria, and Acellular Pertussis Vaccination on Pertussis Severity in Infants. Clinical Infectious Diseases. 64(1). 9–14. 115 indexed citations

Cherry, James D.. (2016). Pertussis in Young Infants Throughout the World. Clinical Infectious Diseases. 63(suppl 4). S119–S122. 64 indexed citations

Cherry, James D. & Christopher D. Paddock. (2014). Pathogenesis and histopathology of pertussis: implications for immunization. Expert Review of Vaccines. 13(9). 1115–1123. 27 indexed citations

Cherry, James D.. (2014). Adult pertussis in the pre- and post-vaccine eras: lifelong vaccine-induced immunity?. Expert Review of Vaccines. 13(9). 1073–1080. 32 indexed citations

Nieves, Delma, John S. Bradley, Wilbert H. Mason, et al.. (2013). Exchange Blood Transfusion in the Management of Severe Pertussis in Young Infants. The Pediatric Infectious Disease Journal. 32(6). 698–699. 38 indexed citations

Murray, Erin L., John S. Bradley, Wilbert H. Mason, et al.. (2013). Characteristics of Severe Bordetella pertussis Infection Among Infants <=90 Days of Age Admitted to Pediatric Intensive Care Units - Southern California, September 2009-June 2011. Journal of the Pediatric Infectious Diseases Society. 2(1). 1–6. 54 indexed citations

Tapiainen, Terhi, James D. Cherry, & Ulrich Heininger. (2005). Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria–tetanus–pertussis vaccines in infants. Vaccine. 23(43). 5106–5112. 7 indexed citations

10.

Ward, Joel I., James D. Cherry, Swei‐Ju Chang, et al.. (2005). Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults. New England Journal of Medicine. 353(15). 1555–1563. 281 indexed citations

11.

Cherry, James D., Swei‐Ju Chang, David L. Klein, et al.. (2004). Prevalence of Antibody toBordetella pertussisAntigens in Serum Specimens Obtained from 1793 Adolescents and Adults. Clinical Infectious Diseases. 39(11). 1715–1718. 22 indexed citations

12.

Forsyth, Kevin, Magda Campins, J. Jaime, et al.. (2004). New Pertussis Vaccination Strategies beyond Infancy: Recommendations by the Global Pertussis Initiative. Clinical Infectious Diseases. 39(12). 1802–1809. 136 indexed citations

13.

Cherry, James D., et al.. (2004). Determination of Serum Antibody toBordetella pertussisAdenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults with Pertussis. Clinical Infectious Diseases. 38(4). 502–507. 37 indexed citations

14.

Heininger, Ulrich, K Stehr, Peter D. Christenson, & James D. Cherry. (1999). Evidence of Efficacy of the Lederle/Takeda Acellular Pertussis Component Diphtheria and Tetanus Toxoids and Pertussis Vaccine but Not the Lederle Whole‐Cell Component Diphtheria and Tetanus Toxoids and Pertussis Vaccine AgainstBordetella parapertussisInfection. Clinical Infectious Diseases. 28(3). 602–604. 36 indexed citations

15.

Cherry, James D. & P Olin. (1999). The Science and Fiction of Pertussis Vaccines. PEDIATRICS. 104(6). 1381–1383. 46 indexed citations

16.

Tuttle, Jessica, et al.. (1997). The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.. American Journal of Public Health. 87(12). 2045–2048. 50 indexed citations

17.

Rantala, Heikki, Peter D. Christenson, Claus Vinther Nielsen, et al.. (1996). Risk Factors of Infantile Spasms Compared with Other Seizures in Children Under 2 Years of Age. Epilepsia. 37(4). 362–366. 11 indexed citations

18.

Heininger, Ulrich, James D. Cherry, Peter D. Christenson, et al.. (1994). Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany. Vaccine. 12(1). 81–86. 57 indexed citations

19.

Salzman, Mark B., et al.. (1991). LEUKOCYTOSIS IN HEMOLYTIC-UREMIC SYNDROME. The Pediatric Infectious Disease Journal. 10(6). 470–470. 10 indexed citations

20.

Cherry, James D., Ralph D. Feigin, Louis A. Lobes, et al.. (1972). Urban measles in the vaccine era: A clinical, epidemiologic, and serologic study. The Journal of Pediatrics. 81(2). 217–230. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact